UA85512C2 - Crth2 receptor ligands for medicinal uses - Google Patents
Crth2 receptor ligands for medicinal usesInfo
- Publication number
- UA85512C2 UA85512C2 UAA200614018A UAA200614018A UA85512C2 UA 85512 C2 UA85512 C2 UA 85512C2 UA A200614018 A UAA200614018 A UA A200614018A UA A200614018 A UAA200614018 A UA A200614018A UA 85512 C2 UA85512 C2 UA 85512C2
- Authority
- UA
- Ukraine
- Prior art keywords
- ring
- monocyclic heteroaryl
- membered monocyclic
- crth2 receptor
- fused
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Compounds of formula (I) are useful for the treatment of disease responsive to modulation of CRTH2 receptor activity, such as asthma, rhinitis, allergic airway syndrome, and allergic rhinobronchitis, wherein A represents a carboxyl group -COON, or a carboxyl bioisostere; A, is I hydrogen or methyl; ring Aris an optionally substituted phenyl ring 5-or 6-membered monocyclic heteroaryl ring, in which AACHO- and L2 are linked to adjacent ring atoms; rings Are, Areach independently represent a phenyl or 5- or 6-membered monocyclic heteroaryl ring, or a bicyclic ring system consisting of a 5- or 6-membered carbocyclic or heterocyclic ring which is benz-fused or fused to a 5- or 6-membered monocyclic heteroaryl ring, said ring or ring system being optionally substituted; t is 0 or 1; L2 and L3 are linker radicals as defined in the description.(I)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0412198A GB0412198D0 (en) | 2004-05-29 | 2004-05-29 | Medicinal use of receptor ligands |
Publications (1)
Publication Number | Publication Date |
---|---|
UA85512C2 true UA85512C2 (en) | 2009-01-26 |
Family
ID=38131507
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200614018A UA85512C2 (en) | 2004-05-29 | 2005-05-30 | Crth2 receptor ligands for medicinal uses |
Country Status (4)
Country | Link |
---|---|
CN (2) | CN1980908A (en) |
EC (2) | ECSP067104A (en) |
UA (1) | UA85512C2 (en) |
ZA (2) | ZA200610598B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102016577B (en) * | 2008-05-09 | 2015-06-17 | 希森美康株式会社 | Blood analyzer, blood analysis method and hemolytic agent |
KR20120098908A (en) | 2009-12-23 | 2012-09-05 | 아이언우드 파마슈티컬스, 인코포레이티드 | Crth2 modulator |
-
2005
- 2005-05-30 CN CN 200580022519 patent/CN1980908A/en active Pending
- 2005-05-30 CN CN2005800226257A patent/CN1980664B/en not_active Expired - Fee Related
- 2005-05-30 UA UAA200614018A patent/UA85512C2/en unknown
-
2006
- 2006-12-15 ZA ZA200610598A patent/ZA200610598B/en unknown
- 2006-12-15 ZA ZA200610597A patent/ZA200610597B/en unknown
- 2006-12-20 EC ECSP067104 patent/ECSP067104A/en unknown
- 2006-12-26 EC ECSP067115 patent/ECSP067115A/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200610597B (en) | 2008-01-30 |
CN1980908A (en) | 2007-06-13 |
CN1980664A (en) | 2007-06-13 |
ZA200610598B (en) | 2008-01-30 |
ECSP067104A (en) | 2007-04-26 |
CN1980664B (en) | 2011-02-23 |
ECSP067115A (en) | 2007-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200602290A1 (en) | CRTH2 LIGANDS RECEPTOR AND THEIR APPLICATION | |
NO20066049L (en) | Substituted thiazole acetic acids as CRTH2 ligands | |
Jablonowski et al. | The first potent and selective non-imidazole human histamine H4 receptor antagonists | |
NO20084350L (en) | Heterocyclic amides for use as pharmaceuticals | |
ATE449090T1 (en) | SUBSTITUTED PIPERAZINE AND DIAZEPANDE DERIVATIVES FOR USE AS HISTAMINE H3 RECEPTOR MODULATORS | |
ES2174757B1 (en) | EMPLOYMENT OF FIRAZOLIN DERIVATIVES IN THE PREPARATION OF A MEDICINAL PRODUCT FOR THE PREVENTION AND / OR TREATMENT OF CELLULAR PROLIFERATIVE DISEASES. | |
BR122017028096B8 (en) | compound, pharmaceutical composition, and use of the compound | |
DE602006007012D1 (en) | PYRIDINE DERIVATIVES AS DIPEPTEDYL-PEPTIDASE INHIBITORS | |
NO20050418L (en) | Condensed pyridines and pyrimidines with TIE2 (TEK) activity | |
ATE365551T1 (en) | FUSIONED HETEROARYL DERIVATIVES FOR USE AS P38 KINASE INHIBITORS FOR THE TREATMENT OF, INCLUDING RHEUMATIC ARTHRITIS | |
HUP0500610A2 (en) | Indazoles, benzothiazoles, and benzoisothiazoles, pharmaceutical compositions comprises thereof and their uses | |
ATE496620T1 (en) | 1H-BENZO(F)INDAZOLE-5-YL DERIVATIVES AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS | |
ATE540021T1 (en) | HYDROXANIC ACID DERIVATIVES AS INHIBITORS OF ENZYMATIC HDAC ACTIVITY | |
WO2007149448A3 (en) | Pyrazinones as cellular proliferation inhibitors | |
ECSP056016A (en) | NEW DERIVATIVES OF 2-PYRIDINACARBOXAMIDA | |
NO20063576L (en) | 1,3-dioxane derivatives and analogous compounds for the treatment of obesity and diabetes | |
EA200702058A1 (en) | NEW PHARMACEUTICAL COMPOUNDS | |
HRP20041137B1 (en) | Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides | |
MX2009010909A (en) | Phthalazinone derivatives and their use as medicament to treat cancer. | |
NO20082917L (en) | Oxadiazole derivatives with CRTH2 receptor activity | |
MY148988A (en) | Terphenyl derivatives for treatment of alzheimer's disease | |
TN2011000380A1 (en) | Triazolopyridine derivatives as p38 map kinase inhibitors | |
AR040626A1 (en) | USEFUL QUINOLINE DERIVATIVES AS NEUROPEPTIDE RECEIVER AND (NPY) | |
DE602008001725D1 (en) | 1- (1-BENZYLPIPERIDIN-4-YL) BENZIMIDAZOLE-5-CARBOXYLENE DERIVATIVES FOR THE TREATMENT OF DIABETES MELLITUS | |
ATE469128T1 (en) | INDOLES SUITABLE FOR THE TREATMENT OF ANDROGEN RECEPTOR-RELATED DISEASES |